Skip to content
ppharmaranks
Menu

Best treatments for urge urinary incontinence

3 products may treat urge urinary incontinence, spanning FDA drug classes such as cholinergic muscarinic antagonist, beta3-adrenergic agonist. The current highest-rated option is trospium chloride. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.

Quick answer: Of the 3 drugs we list for urge urinary incontinence, all are available as lower-cost generics, spanning classes such as cholinergic muscarinic antagonist, beta3-adrenergic agonist. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for urge urinary incontinence — so confirm the right choice with your prescriber.

Rated against independent regulatory sources·Last updated August 19, 2026·How we rate
Treatments we list for urge urinary incontinence
#DrugRatingPharmacy pays
172/100$7View →
2Not yet rated$289View →
3Not yet rated$289View →

Full ranking · 3 treatments

Frequently asked

What treats urge urinary incontinence?
Our catalog lists 3 products that may treat urge urinary incontinence, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is trospium chloride.
What is the best-rated treatment for urge urinary incontinence?
By our independent recall-safety rating — not an efficacy measure — trospium chloride ranks highest among the products we list for urge urinary incontinence. Always consult a professional.
How are these treatments ranked?
By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
What types of drugs treat urge urinary incontinence?
Treatments for urge urinary incontinence span FDA drug classes including cholinergic muscarinic antagonist, beta3-adrenergic agonist. Compare every option side by side, ranked by independent rating, above.

Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.